Liquid biopsy epigenomic profiling for cancer subtypingSylvan C. Baca, Matthew L. Freedman, Ji-Heui Seo et al.|Nature Medicine|2023Cited by 119
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Alexander Gusev, Guihong Wan et al.|Nature Medicine|2022Cited by 106
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C. Baca, Matthew L. Freedman, Ji-Heui Seo et al.|Nature Medicine|2023Cited by 1
Assessment of time-to-treatment-failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic renal cell carcinoma (mRCC): Findings from an IMDC analysis.Zachary A. Yochum, Toni K. Choueiri, Renée Maria Saliby et al.|Journal of Clinical Oncology|2025Cited by 0